Results for tag: "10 Hydroxycamptothecin"

Hydroxycamptothecin (HCPT) is an antineoplastic drug used in the treatment of various types of cancer. It is a topoisomerase I inhibitor, which works by blocking the enzyme topoisomerase I from repairing DNA strands, leading to cell death. HCPT is used in combination with other drugs to treat a variety of cancers, including breast, ovarian, and colorectal cancer. It is also used to treat certain types of leukemia. HCPT is administered intravenously and is generally well tolerated, with few side effects. HCPT is a relatively new drug, and its use in oncology is still being studied. Clinical trials are ongoing to evaluate its efficacy in combination with other drugs. The drug is also being studied for its potential to reduce the risk of recurrence in certain types of cancer. The HCPT market is growing rapidly, as the drug is increasingly being used in combination with other drugs to treat a variety of cancers. The market is expected to continue to grow as more clinical trials are conducted and the drug is approved for use in more countries. Some companies in the HCPT market include Merck, Pfizer, Novartis, and AstraZeneca. Show Less Read more